Stockscreener 앱 받기
4.21
1.20%
0.05
시장 영업 전:
4.34
0.13
+3.09%
전일 마감가:
$4.16
열려 있는:
$4.19
하루 거래량:
112.59K
Relative Volume:
0.62
시가총액:
$208.09M
수익:
$7.15M
순이익/손실:
$-20.60M
주가수익비율:
8.8706
EPS:
0.4746
순현금흐름:
$-97.99M
1주 성능:
+1.94%
1개월 성능:
+19.94%
6개월 성능:
+87.11%
1년 성능:
+161.49%
1일 변동 폭
$4.12
$4.28
1주일 범위
$3.77
$4.33
52주 변동 폭
$1.53
$4.4799
Whitehawk Therapeutics Inc Stock (WHWK) Company Profile
명칭
Whitehawk Therapeutics Inc
전화
551-321-2234
주소
2 HEADQUARTERS PLAZA, MORRISTOWN
Compare WHWK vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WHWK
Whitehawk Therapeutics Inc
|
4.21 | 208.09M | 7.15M | -20.60M | -97.99M | 0.4746 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Whitehawk Therapeutics Inc Stock (WHWK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-05 | 개시 | Oppenheimer | Outperform |
| 2024-08-27 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-08-21 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-08-21 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2023-12-15 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2022-01-11 | 개시 | Jefferies | Buy |
| 2021-10-01 | 개시 | Cowen | Outperform |
| 2021-09-14 | 개시 | Ladenburg Thalmann | Buy |
| 2021-09-08 | 개시 | Piper Sandler | Overweight |
모두보기
Whitehawk Therapeutics Inc 주식(WHWK)의 최신 뉴스
The sustainable advantages Whitehawk Therapeutics (WHWK) is developing (Eye on Rally) 2026-05-05Hot Stocks - Newser
Whitehawk Therapeutics Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
Whitehawk Therapeutics (WHWK) price target increased by 10.29% to 6.38 - MSN
Whitehawk Therapeutics (WHWK) price target increased by 13.33% to 5.78 - MSN
[ARS] Whitehawk Therapeutics, Inc. SEC Filing - Stock Titan
Whitehawk Therapeutics (NASDAQ: WHWK) details 2026 virtual shareholder meeting - Stock Titan
ABG Innovation Capital Partners III GP Ltd's Whitehawk Therapeutics Inc(WHWK) Holding History - GuruFocus
WHWK Whitehawk Therapeutics falls 3.36% as Q4 2025 EPS misses estimates by a wide 116.4 percent margin.Collaborative Trading Signals - Newser
Whitehawk jumps as Citizens issues outperform rating ahead of trial data - MSN
Oppenheimer Maintains Whitehawk Therapeutics(WHWK.US) With Buy Rating, Maintains Target Price $6 - Moomoo
WHWK Whitehawk Therapeutics posts wider than projected Q4 2025 loss, pushing its share price down 3.36% today.Stock Market Community - Newser
Whitehawk Therapeutics' Antibody Drug Conjugates Indicate Potential Efficacy Against Cancer, Oppenheimer Says - Moomoo
H.C. Wainwright Maintains Whitehawk Therapeutics(WHWK.US) With Hold Rating - Moomoo
Whitehawk Therapeutics (WHWK) Unveils New Preclinical Data at AA - GuruFocus
Whitehawk Therapeutics Presents Comprehensive Preclinical Data Highlighting its Next-Generation ADC Portfolio at the AACR 2026 - InsideNoVa.com
What is driving sentiment for Whitehawk Therapeutics (WHWK) stock (On the Radar) 2026-04-18Trending Entry Points - Xã Thanh Hà
Whitehawk Therapeutics CFO sells $882k in stock - Investing.com
Whitehawk Therapeutics CFO sells $882k in stock By Investing.com - Investing.com Australia
Whitehawk Therapeutics Chief Financial Officer Sold Shares Worth Over $882K - TradingView
Whitehawk Therapeutics (WHWK) CFO disposes shares in tax-related broker sales - Stock Titan
Whitehawk Therapeutics to Participate in Jones Trading Post-AACR Fireside Chat Series - The AI Journal
Whitehawk stock wins Outperform rating from Citizens (WHWK) - Seeking Alpha
WHWK Initiated Coverage by Citizens -- Rating Set to Market Outp - GuruFocus
Whitehawk Therapeutics stock initiated with outperform rating at Citizens By Investing.com - Investing.com South Africa
Whitehawk Therapeutics stock initiated with outperform rating at Citizens - Investing.com
Proposed resale lists 473,902 units; insider sold 2,594 shares (WHWK) - Stock Titan
Whitehawk Therapeutics officer Ball sells $427,860 in stock - Investing.com
Whitehawk Therapeutics officer Ball sells $427,860 in stock By Investing.com - Investing.com South Africa
Whitehawk Therapeutics (WHWK) officer sells 118,849 shares for RSU tax withholding - Stock Titan
WHWK Stock Price and Chart — NASDAQ:WHWK - TradingView
Discovering Whitehawk Therapeutics Among 3 Promising Penny Stocks - Yahoo Finance
Whitehawk Therapeutics officer Ball sells $201k in stock By Investing.com - Investing.com South Africa
Whitehawk Therapeutics officer Ball sells $201k in stock - Investing.com
Whitehawk Therapeutics (WHWK) insider disposes 56,596 shares for tax withholding - Stock Titan
EV Market: Will Whitehawk Therapeutics Inc benefit from government policyWeekly Stock Report & Free Community Supported Trade Ideas - baoquankhu1.vn
WHWK SEC FilingsWhitehawk Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Trade Alert: President Of Whitehawk Therapeutics David Lennon Has Sold Stock - simplywall.st
Whitehawk Therapeutics CEO Lennon sells $49k in shares By Investing.com - Investing.com Australia
Whitehawk Therapeutics Inc (WHWK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.14%
0.48%
자본화:
|
볼륨(24시간):